Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 2
1952 1
1964 2
1970 4
1971 1
1973 1
1976 1
1977 2
1980 1
1983 1
1984 3
1985 2
1986 2
1987 1
1988 4
1989 1
1990 3
1991 4
1992 1
1993 4
1994 2
1995 5
1996 4
1998 5
1999 3
2000 3
2001 2
2002 3
2003 1
2004 6
2005 4
2006 2
2007 5
2008 6
2009 2
2010 2
2011 8
2012 6
2013 4
2014 6
2015 6
2016 5
2017 7
2018 9
2019 13
2020 13
2021 17
2022 25
2023 19
2024 14
2025 10
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

246 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for jordan lactam
Search for Jordan Lacam instead (1 results)
Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel beta-Lactams and beta-Lactam/beta-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation.
Bakdach D, Elajez R, Bakdach AR, Awaisu A, De Pascale G, Ait Hssain A. Bakdach D, et al. J Clin Med. 2022 Nov 22;11(23):6898. doi: 10.3390/jcm11236898. J Clin Med. 2022. PMID: 36498473 Free PMC article. Review.
OBJECTIVE: Dose optimization of novel beta-lactam antibiotics (NBLA) has become necessary given the increased prevalence of multidrug-resistant infections in intensive care units coupled with the limited number of available treatment options. ...
OBJECTIVE: Dose optimization of novel beta-lactam antibiotics (NBLA) has become necessary given the increased prevalence of multidrug …
[Chronic meningococcemia].
Martínez JV, Verbanaz SC, Jordán R, Enríquez N, Efrón ED. Martínez JV, et al. Medicina (B Aires). 2008;68(4):298-300. Medicina (B Aires). 2008. PMID: 18786886 Spanish.
It has been hypothesized that owing to high susceptibility to beta-lactam antibiotics of Neisseria meningitidis, many cases may be treated inadvertently. ...
It has been hypothesized that owing to high susceptibility to beta-lactam antibiotics of Neisseria meningitidis, many cases may be tr …
[Cephalosporins in clinical practice].
Jordan E, Voide C, Petignat PA, Gobin N. Jordan E, et al. Rev Med Suisse. 2020 Oct 14;16(710):1906-1911. Rev Med Suisse. 2020. PMID: 33058575 Review. French.
Carbapenemases: Partners in crime.
Bush K. Bush K. J Glob Antimicrob Resist. 2013 Mar;1(1):7-16. doi: 10.1016/j.jgar.2013.01.005. Epub 2013 Mar 1. J Glob Antimicrob Resist. 2013. PMID: 27873609 Review.
Carbapenemases, beta-lactamases that inactivate carbapenems and most beta-lactam antibiotics, are most widely known for their ability to confer resistance to beta-lactams. ...
Carbapenemases, beta-lactamases that inactivate carbapenems and most beta-lactam antibiotics, are most widely known for their ability …
NECROTIZING FASCITIS.
CROSTHWAIT RW Jr, CROSTHWAIT RW, JORDAN GL Jr. CROSTHWAIT RW Jr, et al. J Trauma. 1964 Mar;4:149-57. doi: 10.1097/00005373-196403000-00001. J Trauma. 1964. PMID: 14151147 No abstract available.
Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant Gram-negative bacterial pathogens in Lebanon, Jordan and Iraq.
Moghnieh RA, Moussa JA, Aziz MA, Matar GM. Moghnieh RA, et al. J Glob Antimicrob Resist. 2021 Dec;27:175-199. doi: 10.1016/j.jgar.2021.08.005. Epub 2021 Sep 1. J Glob Antimicrob Resist. 2021. PMID: 34481122 Free article. Review.
Sixty-seven relevant articles published within the past 5 years highlighting trends in AMR in Lebanon, Jordan and Iraq were included. Increased resistance to carbapenems in Acinetobacter spp. isolates was observed in Lebanon, Jordan and Iraq; colistin resistance rem …
Sixty-seven relevant articles published within the past 5 years highlighting trends in AMR in Lebanon, Jordan and Iraq were included. …
Collaterally Sensitive beta-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms.
Hashmi HB, Farooq MA, Khan MH, Alshammari A, Aljasham AT, Rashid SA, Khan NR, Hashmi IB, Badar M, Mubarak MS. Hashmi HB, et al. Pharmaceuticals (Basel). 2023 May 2;16(5):687. doi: 10.3390/ph16050687. Pharmaceuticals (Basel). 2023. PMID: 37242471 Free PMC article.
The current study focused on evaluating the efficacy of three beta-lactam drugs, meropenem, piperacillin, and tazobactam, alone and in combination against the MRSA biofilms. ...Although the mechanism of synergism is not fully understood, our findings suggest that these thr …
The current study focused on evaluating the efficacy of three beta-lactam drugs, meropenem, piperacillin, and tazobactam, alone and i …
246 results